---
title: "US FDA approves weight loss drug Wegovy to prevent cardiovascular events"
date: "2024-03-11T10:39:14.000Z"
publishedDate: "11 mars 2024"
summary: "The US Food and Drug Administration (FDA) has approved an additional indication for the weight loss drug semaglutide—marketed as Wegovy (Novo Nordisk) —to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet [&#8230;] The post US FDA approves weight loss drug Wegovy to prevent cardiovascular events appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/us-fda-approves-weight-loss-drug-wegovy-to-prevent-cardiovascular-events/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-03-11-us-fda-approves-weight-loss-drug-wegovy-to-prevent-cardiovascular-events"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/03/BrandPhoto1_1709582661089-HR-scaled.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-approves-weight-loss-drug-wegovy-to-prevent-cardiovascular-events/"
---

![US FDA approves weight loss drug Wegovy to prevent cardiovascular events](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/03/BrandPhoto1_1709582661089-HR-scaled.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-approves-weight-loss-drug-wegovy-to-prevent-cardiovascular-events/*

## L’essentiel

The US Food and Drug Administration (FDA) has approved an additional indication for the weight loss drug semaglutide—marketed as Wegovy (Novo Nordisk) —to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet [&#8230;] The post US FDA approves weight loss drug Wegovy to prevent cardiovascular events appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/us-fda-approves-weight-loss-drug-wegovy-to-prevent-cardiovascular-events/
